Search Header Logo
Eli Lilly To Supply COVID-19 Treatment To Low-Income Countries

Eli Lilly To Supply COVID-19 Treatment To Low-Income Countries

Assessment

Interactive Video

Health Sciences, Biology

University

Practice Problem

Hard

Created by

Wayground Content

FREE Resource

Eli Lilly has partnered with the Bill and Melinda Gates Foundation to provide a potential COVID-19 antibody treatment. The company emphasizes the importance of medicines in combating the pandemic and aims to produce 1,000,000 doses by year-end. However, the exact availability remains unclear. Meanwhile, President Trump is urging the FDA to expedite approval for this treatment and another by Regeneron for emergency use.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which organization has the pharmaceutical company partnered with to provide a potential COVID-19 antibody treatment?

Bill and Melinda Gates Foundation

United Nations

Centers for Disease Control and Prevention

World Health Organization

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main goal of the medicines discussed by Eli Lilly's chairman and CEO?

To treat other diseases

To replace vaccines

To reduce the impact of COVID-19

To increase company profits

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many doses of the treatment does Eli Lilly aim to have by the end of the year?

750,000

2,000,000

1,000,000

500,000

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What action is President Trump taking regarding the antibody treatment?

He is funding the research

He is urging the FDA to approve it for emergency use

He is distributing it to hospitals

He is testing it himself

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which other company's treatment is mentioned alongside Eli Lilly's for emergency use approval?

Johnson & Johnson

Pfizer

Moderna

Regeneron

Access all questions and much more by creating a free account

Create resources

Host any resource

Get auto-graded reports

Google

Continue with Google

Email

Continue with Email

Classlink

Continue with Classlink

Clever

Continue with Clever

or continue with

Microsoft

Microsoft

Apple

Apple

Others

Others

Already have an account?